Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study

Fig. 3

Forest plots for 30%, 40%, and 50% estimated glomerular filtration rate (eGFR) reduction of SGLT-2is versus oGLDs in overall study cohort and subgroups stratified by baseline eGFR level (i.e., ≤ 60, < 60–90, > 90 mL/min/1.73 m2) (intention-to-treat analysis). CI confidence interval, oGLDs other glucose-lowering drugs, SE standard error, SGLT-2is sodium glucose cotransporter-2 inhibitors

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840